The process of transplantation is used as an effective way to treat deadly human diseases. But, extreme caution is needed before the process of transplantation can be made. Also, the human cells that is used for transplantation must be properly evaluated and watch out. That is why the Food and Drug Administration is given the authority by law to regulate the use of human tissue. Human tissue regulation is derived from the provisions set unto the Title 21 of the Code of Federal Regulations or commonly known as the 21 CFR. The Food and Drug Administration also regulates the human cells used for implantation, infusion, and transfer to human recipients which would bring total risk if not properly executed. The Center for Biologics Evaluation and Research or CBER is the branch of the Food and Drug Administration that is tasked to set the rules in order to make the regulation smooth and effective.